Peripheral peptide YY inhibits propulsive colonic motor function through Y2 receptor in conscious mice

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 298, Issue 1, 2010, Pages

  Wang, Lixin ^a   Gourcerol, Guillaume ^a   Yuan, Pu Qing ^a   Wu, S Vincent ^a   Million, Mulugeta ^a   Larauche, Muriel ^a   Taché, Yvette ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bethanechol; PYY3 36; Serotonin; Stress

Indexed keywords

5 HYDROXYTRYPTOPHAN; ASTRESSIN; ASTRESSIN2 B; BETHANECHOL; CORTICOTROPHIN RELEASING FACTOR RELEASING FACTOR RECEPTOR ANTAGONIST; N [2 [1,2 DIHYDRO 3,5(4H) DIOXO 1,2 DIPHENYL 1,2,4 TRIAZOL 4 YL]ETHYL] N2 [[1 [2 [4 [5,11 DIHYDRO 6(6H) OXODIBENZ[B,E]AZEPIN 11 YL] 1 PIPERAZINYL] 2 OXOETHYL]CYCLOPENTYL]ACETYL]ARGININAMIDE; NEUROPEPTIDE Y; NEUROPEPTIDE Y [31 LEUCINE 34 PROLINE]; NEUROPEPTIDE Y RECEPTOR AGONIST; NEUROPEPTIDE Y1 RECEPTOR; NEUROPEPTIDE Y2 RECEPTOR; NEUROPEPTIDE Y5 RECEPTOR; PEPTIDE YY; PEPTIDE YY [3-36]; PROTEIN INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLON MOTILITY; CONTROLLED STUDY; DEFECATION; DESCENDING COLON; DIARRHEA; DIET RESTRICTION; FOOD INTAKE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTESTINE PRESSURE; MALE; MOTOR PERFORMANCE; MOUSE; NERVE CELL; NERVE ENDING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STOMACH EMPTYING; STRESS;

5-HYDROXYTRYPTOPHAN; ACUTE DISEASE; ANIMALS; ARGININE; BENZAZEPINES; BETHANECHOL; COLON; CONSCIOUSNESS; DIARRHEA; EATING; EFFERENT PATHWAYS; GASTRIC EMPTYING; GASTROINTESTINAL MOTILITY; MALE; MICE; MICE, INBRED C57BL; MYENTERIC PLEXUS; NEUROPEPTIDE Y; PARASYMPATHOMIMETICS; PEPTIDE YY; RECEPTORS, NEUROPEPTIDE Y; RESTRAINT, PHYSICAL; STRESS, PHYSIOLOGICAL;

EID: 73549124518     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00349.2009     Document Type: Article

References (70)

1. Adams SH, Won WB, Schonhoff SE, Leiter AB, Paterniti JR Jr. Effects of peptide YY[3-36] on short-term food intake in mice are not affected by prevailing plasma ghrelin levels. Endocrinology 145: 4967-4975, 2004.
2. Arantes RM, Nogueira AM. Distribution of enteroglucagon- and peptide YY-immunoreactive cells in the intestinal mucosa of germ-free and conventional mice. Cell Tissue Res 290: 61-69, 1997.
3. Balasubramaniam A. Neuropeptide Y (NPY) family of hormones: progress in the development of receptor selective agonists and antagonists. Curr Pharm Des 9: 1165-1175, 2003.
4. Batterham RL, Cowley MA, Small CJ, Herzog H, Cohen MA, Dakin CL, Wren AM, Brynes AE, Low MJ, Ghatei MA, Cone RD, Bloom SR. Gut hormone PYY(3-36) physiologically inhibits food intake. Nature 418: 650-654, 2002.
5. Browning KN, Lees GM. Inhibitory effects of NPY on ganglionic transmission in myenteric neurones of the guinea-pig descending colon. Neurogastroenterol Motil 12: 33-41, 2000.
6. Brumovsky P, Stanic D, Shuster S, Herzog H, Villar M, Hokfelt T. Neuropeptide Y2 receptor protein is present in peptidergic and nonpeptidergic primary sensory neurons of the mouse. J Comp Neurol 489: 328-348, 2005.
7. Chang J, Hoy JJ, Idumalla PS, Clifton MS, Pecoraro NC, Bhargava A. Urocortin 2 expression in the rat gastrointestinal tract under basal conditions and in chemical colitis. Peptides 28: 1453-1460, 2007.
8. Chelikani PK, Haver AC, Reidelberger RD. Comparison of the inhibitory effects of PYY(3-36) and PYY(1-36) on gastric emptying in rats. Am J Physiol Regul Integr Comp Physiol 287: R1064-R1070, 2004.
9. Cherbut C, Ferrier L, Roze C, Anini Y, Blottiere H, Lecannu G, Galmiche JP. Short-chain fatty acids modify colonic motility through nerves and polypeptide YY release in the rat. Am J Physiol Gastrointest Liver Physiol 275: G1415-G1422, 1998.
10. Cox HM. Neuropeptide Y receptors; antisecretory control of intestinal epithelial function. Auton Neurosci 133: 76-85, 2007.
11. Diener M, Knobloch SF, Bridges RJ, Keilmann T, Rummel W. Cholinergic-mediated secretion in the rat colon: neuronal and epithelial muscarinic responses. Eur J Pharmacol 168: 219-229, 1989.
12. Doods H, Gaida W, Wieland HA, Dollinger H, Schnorrenberg G, Esser F, Engel W, Eberlein W, Rudolf K. BIIE0246: a selective and high affinity neuropeptide Y Y(2) receptor antagonist. Eur J Pharmacol 384: R3-R5, 1999.
13. Dumont Y, Cadieux A, Pheng LH, Fournier A, St Pierre S, Quirion R. Peptide YY derivatives as selective neuropeptide Y/peptide YY Y1 and Y2 agonists devoided of activity for the Y3 receptor sub-type. Brain Res Mol Brain Res 26: 320-324, 1994.
14. Ekblad E, Sundler F. Distribution of pancreatic polypeptide and peptide YY. Peptides 23: 251-261, 2002.
15. El Salhy M, Suhr O, Danielsson A. Peptide YY in gastrointestinal disorders. Peptides 23: 397-402, 2002.
16. Ferrier L, Segain JP, Bonnet C, Cherbut C, Lehur PA, Jarry A, Galmiche JP, Blottiere HM. Functional mapping of NPY/PYY receptors in rat and human gastro-intestinal tract. Peptides 23: 1765-1771, 2002.
17. Ferrier L, Segain JP, Pacaud P, Cherbut C, Loirand G, Galmiche JP, Blottiere HM. Pathways and receptors involved in peptide YY induced contraction of rat proximal colonic muscle in vitro. Gut 46: 370-375, 2000.
18. Goumain M, Voisin T, Lorinet AM, Ducroc R, Tsocas A, Roze C, Rouet-Benzineb P, Herzog H, Balasubramaniam A, Laburthe M. The peptide YY-preferring receptor mediating inhibition of small intestinal secretion is a peripheral Y(2) receptor: pharmacological evidence and molecular cloning. Mol Pharmacol 60: 124-134, 2001.
19. Goumain M, Voisin T, Lorinet AM, Laburthe M. Identification and distribution of mRNA encoding the Y1, Y2, Y4, and Y5 receptors for peptides of the PP-fold family in the rat intestine and colon. Biochem Biophys Res Commun 247: 52-56, 1998.
20. Gourcerol G, Wang L, Adelson DW, Larauche M, Taché Y, Million M. Cholinergic giant migrating contractions in conscious mouse colon assessed by using a novel noninvasive solid-state manometry method: modulation by stressors. Am J Physiol Gastrointest Liver Physiol 296: G992-G1002, 2009.
21. Grandt D, Schimiczek M, Beglinger C, Layer P, Goebell H, Eysselein VE, Reeve JR Jr. Two molecular forms of peptide YY (PYY) are abundant in human blood: characterization of a radioimmunoassay recognizing PYY 1-36 and PYY 3-36. Regul Pept 51: 151-159, 1994.
22. Grider JR. Neurotransmitters mediating the intestinal peristaltic reflex in the mouse. J Pharmacol Exp Ther 307: 460-467, 2003.
23. Halatchev IG, Cone RD. Peripheral administration of PYY(3-36) produces conditioned taste aversion in mice. Cell Metab 1: 159-168, 2005.
24. Halatchev IG, Ellacott KL, Fan W, Cone RD. Peptide YY3-36 inhibits food intake in mice through a melanocortin-4 receptor-independent mechanism. Endocrinology 145: 2585-2590, 2004.
25. Hellstrom PM. Mechanisms involved in colonic vasoconstriction and inhibition of motility induced by neuropeptide Y. Acta Physiol Scand 129: 549-556, 1987.
26. Hyland NP, Cox HM. The regulation of veratridine-stimulated electrogenic ion transport in mouse colon by neuropeptide Y (NPY), Y1 and Y2 receptors. Br J Pharmacol 146: 712-722, 2005.
27. Hyland NP, Sjoberg F, Tough IR, Herzog H, Cox HM. Functional consequences of neuropeptide Y Y2 receptor knockout and Y2 antagonism in mouse and human colonic tissues. Br J Pharmacol 139: 863-871, 2003.
28. Jackerott M, Larsson LI. Immunocytochemical localization of the NPY/PYY Y1 receptor in enteric neurons, endothelial cells, and endocrine-like cells of the rat intestinal tract. J Histochem Cytochem 45: 1643-1650, 1997.
29. Jin H, Cai L, Lee K, Chang TM, Li P, Wagner D, Chey WY. A physiological role of peptide YY on exocrine pancreatic secretion in rats. Gastroenterology 105: 208-215, 1993.
30. Kamiji MM, Inui A. Neuropeptide y receptor selective ligands in the treatment of obesity. Endocr Rev 28: 664-684, 2007.
31. Keire DA, Bowers CW, Solomon TE, Reeve JR Jr. Structure and receptor binding of PYY analogs. Peptides 23: 305-321, 2002.
32. Kimura T, Amano T, Uehara H, Ariga H, Ishida T, Torii A, Tajiri H, Matsueda K, Yamato S. Urocortin I is present in the enteric nervous system and exerts an excitatory effect via cholinergic and serotonergic pathways in the rat colon. Am J Physiol Gastrointest Liver Physiol 293: G903-G910, 2007.
33. Lin HC, Zhao XT, Wang L, Wong H. Fat-induced ileal brake in the dog depends on peptide YY. Gastroenterology 110: 1491-1495, 1996.
34. Lin S, Boey D, Herzog H. NPY and Y receptors: lessons from transgenic and knockout models. Neuropeptides 38: 189-200, 2004.
35. Liu M, Geddis MS, Wen Y, Setlik W, Gershon MD. Expression and function of 5-HT4 receptors in the mouse enteric nervous system. Am J Physiol Gastrointest Liver Physiol 289: G1148-G1163, 2005.
36. Liu S, Gao N, Hu HZ, Wang X, Wang GD, Fang X, Gao X, Xia Y, Wood JD. Distribution and chemical coding of corticotropin-releasing factor-immunoreactive neurons in the guinea pig enteric nervous system. J Comp Neurol 494: 63-74, 2006.
37. Lundberg JM, Tatemoto K, Terenius L, Hellstrom PM, Mutt V, Hokfelt T, Hamberger B. Localization of peptide YY (PYY) in gastrointestinal endocrine cells and effects on intestinal blood flow and motility. Proc Natl Acad Sci USA 79: 4471-4475, 1982.
38. Mangel AW, Fitz JG, Taylor IL. Modulation of colonic motility by substance P, cholecystokinin and neuropeptide Y. Peptides 12: 1063-1067, 1991.
39. Martinez V, Wang L, Rivier J, Grigoriadis D, Taché Y. Central CRF, urocortins and stress increase colonic transit via CRF1 receptors while activation of CRF2 receptors delays gastric transit in mice. J Physiol 556: 221-234, 2004.
40. Martinez V, Wang L, Rivier JE, Vale W, Taché Y. Differential actions of peripheral corticotropin-releasing factor (CRF), urocortin II, and urocortin III on gastric emptying and colonic transit in mice: role of CRF receptor subtypes 1 and 2. J Pharmacol Exp Ther 301: 611-617, 2002.
41. Michel MC, Beck-Sickinger A, Cox H, Doods HN, Herzog H, Larhammar D, Quirion R, Schwartz T, Westfall T. XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol Rev 50: 143-150, 1998.
42. Million M, Wang L, Stenzel-Poore MP, Coste SC, Yuan PQ, Lamy C, Rivier J, Buffington T, Taché Y. Enhanced pelvic responses to stressors in female CRF-overexpressing mice. Am J Physiol Regul Integr Comp Physiol 292: R1429-R1438, 2007.
43. Nonaka N, Shioda S, Niehoff ML, Banks WA. Characterization of blood-brain barrier permeability to PYY3-36 in the mouse. J Pharmacol Exp Ther 306: 948-953, 2003.
44. Onaga T, Zabielski R, Kato S. Multiple regulation of peptide YY secretion in the digestive tract. Peptides 23: 279-290, 2002.
45. Ortiz AA, Milardo LF, Decarr LB, Buckholz TM, Mays MR, Claus TH, Livingston JN, Mahle CD, Lumb KJ. A novel long-acting selective neuropeptide Y2 receptor polyethylene glycol-conjugated peptide agonist reduces food intake and body weight and improves glucose metabolism in rodents. J Pharmacol Exp Ther 323: 692-700, 2007.
46. Osinski MA, Seifert TR, Cox BF, Gintant GA. An improved method of evaluation of drug-evoked changes in gastric emptying in mice. J Pharmacol Toxicol Methods 47: 115-120, 2002.
47. Parker E, Van Heek M, Stamford A. Neuropeptide Y receptors as targets for anti-obesity drug development: perspective and current status. Eur J Pharmacol 440: 173-187, 2002.
48. Pheng LH, Perron A, Quirion R, Cadieux A, Fauchere JL, Dumont Y, Regoli D. Neuropeptide Y-induced contraction is mediated by neuropeptide Y Y2 and Y4 receptors in the rat colon. Eur J Pharmacol 374: 85-91, 1999.
49. Pheng LH, Regoli D. Receptors for NPY in peripheral tissues bioassays. Life Sci 67: 847-862, 2000.
50. Pironi L, Stanghellini V, Miglioli M, Corinaldesi R, De Giorgio R, Ruggeri E, Tosetti C, Poggioli G, Morselli Labate AM, Monetti N. Fat-induced ileal brake in humans: a dose-dependent phenomenon correlated to the plasma levels of peptide YY. Gastroenterology 105: 733-739, 1993.
51. Rivier J, Gulyas J, Kirby D, Low W, Perrin MH, Kunitake K, DiGruccio M, Vaughan J, Reubi JC, Waser B, Koerber SC, Martinez V, Wang L, Taché Y, Vale W. Potent and long-acting corticotropin releasing factor (CRF) receptor 2 selective peptide competitive antagonists. J Med Chem 45: 4737-4747, 2002.
52. Sanger GJ, Banner SE, Smith MI, Wardle KA. SB-207266: 5-HT4 receptor antagonism in human isolated gut and prevention of 5-HT-evoked sensitization of peristalsis and increased defaecation in animal models. Neurogastroenterol Motil 10: 271-279, 1998.
53. Sanger GJ, Yoshida M, Yahyah M, Kitazumi K. Increased defecation during stress or after 5-hydroxytryptophan: selective inhibition by the 5-HT(4) receptor antagonist, SB-207266. Br J Pharmacol 130: 706-712, 2000.
54. Savage AP, Adrian TE, Carolan G, Chatterjee VK, Bloom SR. Effects of peptide YY (PYY) on mouth to caecum intestinal transit time and on the rate of gastric emptying in healthy volunteers. Gut 28: 166-170, 1987.
55. Sawa T, Mameya S, Yoshimura M, Itsuno M, Makiyama K, Niwa M, Taniyama K. Differential mechanism of peptide YY and neuropeptide Y in inhibiting motility of guinea-pig colon. Eur J Pharmacol 276: 223-230, 1995.
56. Scott V, Kimura N, Stark JA, Luckman SM. Intravenous peptide YY3-36 and Y2 receptor antagonism in the rat: effects on feeding behaviour. J Neuroendocrinol 17: 452-457, 2005.
57. Silva AP, Cavadas C, Grouzmann E. Neuropeptide Y and its receptors as potential therapeutic drug targets. Clin Chim Acta 326: 3-25, 2002.
58. Talsania T, Anini Y, Siu S, Drucker DJ, Brubaker PL. Peripheral exendin-4 and peptide YY(3-36) synergistically reduce food intake through different mechanisms in mice. Endocrinology 146: 3748-3756, 2005.
59. Tatemoto K, Mutt V. Isolation of two novel candidate hormones using a chemical method for finding naturally occurring polypeptides. Nature 285: 417-418, 1980.
60. Tebbe JJ, Tebbe CG, Mronga S, Ritter M, Schafer MK. Central neuropeptide Y receptors are involved in 3rd ventricular ghrelin induced alteration of colonic transit time in conscious fed rats (Abstract). BMC Gastroenterol 5: 5, 2005.
61. Van Citters GW, Lin HC. Ileal brake: neuropeptidergic control of intestinal transit. Curr Gastroenterol Rep 8: 367-373, 2006.
62. Wager-Page SA, Ghazali B, Anderson W, Veale WL, Davison JS. The peripheral modulation of duodenal and colonic motility in rats by the pancreatic polypeptide-fold family: neuropeptide Y, peptide YY, and pancreatic polypeptide. Peptides 14: 153-160, 1993.
63. Wager-Page SA, Raizada E, Veale W, Davison JS. Peripheral modulation of duodenal and colonic motility and arterial pressure by neuropeptide Y, neuropeptide Y fragment 13-36, peptide YY, and pancreatic polypeptide in rats: cholinergic mechanisms. Can J Physiol Pharmacol 71: 768-775, 1993.
64. Wang L, Martinez V, Kimura H, Taché Y. 5-Hydroxytryptophan activates colonic myenteric neurons and propulsive motor function through 5-HT4 receptors in conscious mice. Am J Physiol Gastrointest Liver Physiol 292: G419-G428, 2007.
65. Wang L, Martinez V, Rivier JE, Taché Y. Peripheral urocortin inhibits gastric emptying and food intake in mice: differential role of CRF receptor 2. Am J Physiol Regul Integr Comp Physiol 281: R1401-R1410, 2001.
66. Whited KL, Tso P, Raybould HE. Involvement of apolipoprotein A-IV and cholecystokinin1 receptors in exogenous peptide YY3 36-induced stimulation of intestinal feedback. Endocrinology 148: 4695-4703, 2007.
67. Wood JD. Enteric nervous system: reflexes, pattern generators and motility. Curr Opin Gastroenterol 24: 149-158, 2008.
68. Wultsch T, Painsipp E, Thoeringer CK, Herzog H, Sperk G, Holzer P. Endogenous neuropeptide Y depresses the afferent signaling of gastric acid challenge to the mouse brainstem via neuropeptide Y type Y2 and Y4 receptors. Neuroscience 136: 1097-1107, 2005.
69. Yuan PQ, Million M, Wu SV, Rivier J, Taché Y. Peripheral corticotropin releasing factor (CRF) and a novel CRF1 receptor agonist, stressin1-A activate CRF1 receptor expressing cholinergic and nitrergic myenteric neurons selectively in the colon of conscious rats. Neurogastroenterol Motil 19: 923-936, 2007.
70. Zhang J, Halm ST, Halm DR. Adrenergic activation of electrogenic K+ secretion in guinea pig distal colonic epithelium: desensitization via the Y2-neuropeptide receptor. Am J Physiol Gastrointest Liver Physiol 297: G278-G291, 2009.